These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2791504)
1. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp. Dubois J; Joly JR Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. Dubois J; St-Pierre C Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains. Edelstein PH; Gaudet EA; Edelstein MA Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505 [TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone. Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500 [TBL] [Abstract][Full Text] [Related]
5. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance. Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485 [TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp. Dubois J; St-Pierre C J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates. Gooding BB; Erwin ME; Barrett MS; Johnson DM; Jones RN Antimicrob Agents Chemother; 1992 Sep; 36(9):2049-50. PubMed ID: 1329642 [TBL] [Abstract][Full Text] [Related]
8. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina. Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328 [TBL] [Abstract][Full Text] [Related]
9. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa. Aldridge KE; Henderberg A; Sanders CV Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219 [TBL] [Abstract][Full Text] [Related]
10. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages. Edelstein PH; Edelstein MA Antimicrob Agents Chemother; 1989 Dec; 33(12):2132-6. PubMed ID: 2619277 [TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates. Wright DN; Saxon B; Matsen JM Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501 [TBL] [Abstract][Full Text] [Related]
12. Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation. Marco F; Biedenbach DJ; Jones RN Diagn Microbiol Infect Dis; 1997 Sep; 29(1):55-7. PubMed ID: 9350417 [TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp. Dubois J; Joly JR J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954 [TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of lomefloxacin activity in Colombia. Trujillo H; Mejia GI; Castrillon L; Gomez C Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):51S-52S. PubMed ID: 2791498 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela. Torres JR Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. Kenny GE; Cartwright FD Antimicrob Agents Chemother; 1991 Mar; 35(3):587-9. PubMed ID: 1903913 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility study of BMS-284756 against Legionella species. Dubois J; St-Pierre C Diagn Microbiol Infect Dis; 2001; 41(1-2):79-82. PubMed ID: 11687318 [TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results. Ruckdeschel G; Dalhoff A J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872 [TBL] [Abstract][Full Text] [Related]
19. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing. Stout JE; Sens K; Mietzner S; Obman A; Yu VL Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309 [TBL] [Abstract][Full Text] [Related]
20. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia. Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]